Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ethnic sensitivity assessment: Polatuzumab vedotin pharmacokinetics in Asian and non-Asian patients with previously untreated diffuse large B-cell lymphoma in POLARIX.
Liao MZ, Deng R, Gibiansky L, Lu T, Agarwal P, Dere R, Lee C, Hirata J, Herbaux C, Salles G, Li C, Miles D. Liao MZ, et al. Among authors: gibiansky l. Clin Transl Sci. 2023 Dec;16(12):2744-2755. doi: 10.1111/cts.13669. Epub 2023 Oct 31. Clin Transl Sci. 2023. PMID: 37864313 Free PMC article.
AQUAVAN injection, a water-soluble prodrug of propofol, as a bolus injection: a phase I dose-escalation comparison with DIPRIVAN (part 2): pharmacodynamics and safety.
Struys MM, Vanluchene AL, Gibiansky E, Gibiansky L, Vornov J, Mortier EP, Van Bortel L. Struys MM, et al. Among authors: gibiansky e, gibiansky l. Anesthesiology. 2005 Oct;103(4):730-43. doi: 10.1097/00000542-200510000-00011. Anesthesiology. 2005. Retraction in: Anesthesiology. 2010 Apr;112(4):1056-7. doi: 10.1097/ALN.0b013e3181d536df Retraction in: Anesthesiology. 2010 Apr;112(4):1058. PMID: 16192765 Free article. Retracted. Clinical Trial.
Inhaled innate immune ligands to prevent pneumonia.
Evans SE, Tuvim MJ, Fox CJ, Sachdev N, Gibiansky L, Dickey BF. Evans SE, et al. Among authors: gibiansky l. Br J Pharmacol. 2011 May;163(1):195-206. doi: 10.1111/j.1476-5381.2011.01237.x. Br J Pharmacol. 2011. PMID: 21250981 Free PMC article. Review.
Facilitating pharmacometric workflow with the metrumrg package for R.
Bergsma TT, Knebel W, Fisher J, Gillespie WR, Riggs MM, Gibiansky L, Gastonguay MR. Bergsma TT, et al. Among authors: gibiansky l. Comput Methods Programs Biomed. 2013 Jan;109(1):77-85. doi: 10.1016/j.cmpb.2012.08.009. Epub 2012 Sep 29. Comput Methods Programs Biomed. 2013. PMID: 23026560
Population pharmacodynamic modeling of various extended-release formulations of methylphenidate in children with attention deficit hyperactivity disorder via meta-analysis.
Kimko H, Gibiansky E, Gibiansky L, Starr HL, Berwaerts J, Massarella J, Wiegand F. Kimko H, et al. Among authors: gibiansky e, gibiansky l. J Pharmacokinet Pharmacodyn. 2012 Apr;39(2):161-76. doi: 10.1007/s10928-011-9238-9. Epub 2012 Jan 22. J Pharmacokinet Pharmacodyn. 2012. PMID: 22270322
Integrated Two-Analyte Population Pharmacokinetic Model for Antibody-Drug Conjugates in Patients: Implications for Reducing Pharmacokinetic Sampling.
Lu D, Gibiansky L, Agarwal P, Dere RC, Li C, Chu YW, Hirata J, Joshi A, Jin JY, Girish S. Lu D, et al. Among authors: gibiansky l. CPT Pharmacometrics Syst Pharmacol. 2016 Dec;5(12):665-673. doi: 10.1002/psp4.12137. Epub 2016 Nov 10. CPT Pharmacometrics Syst Pharmacol. 2016. PMID: 27863168 Free PMC article. Clinical Trial.
Platform model describing pharmacokinetic properties of vc-MMAE antibody-drug conjugates.
Kågedal M, Gibiansky L, Xu J, Wang X, Samineni D, Chen SC, Lu D, Agarwal P, Wang B, Saad O, Koppada N, Fine BM, Jin JY, Girish S, Li C. Kågedal M, et al. Among authors: gibiansky l. J Pharmacokinet Pharmacodyn. 2017 Dec;44(6):537-548. doi: 10.1007/s10928-017-9544-y. Epub 2017 Sep 16. J Pharmacokinet Pharmacodyn. 2017. PMID: 28918591
Bayesian Population Model of the Pharmacokinetics of Venetoclax in Combination with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: Results from the Phase III MURANO Study.
Deng R, Gibiansky L, Lu T, Agarwal P, Ding H, Li X, Kshirsagar S, Lu D, Li C, Girish S, Wang J, Boyer M, Humphrey K, Freise KJ, Salem AH, Seymour JF, Kater AP, Miles D. Deng R, et al. Among authors: gibiansky l. Clin Pharmacokinet. 2019 Dec;58(12):1621-1634. doi: 10.1007/s40262-019-00788-8. Clin Pharmacokinet. 2019. PMID: 31209657 Clinical Trial.
63 results